Spike (B.1.351 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)

Product Code
78142-2
$5,040.00
Order Support
Shipping Information
Product Updates
  • Keep up to date with product offers, resources and news

  • Sign up

The Spike (SARS-CoV-2) (B.1.351) Pseudotyped Lentivirus were produced with SARS-CoV-2 B.1.351 Variant Spike (Genbank Accession #QHD43416.1 with B.1.351 mutations (L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G, A701V) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) (B.1.351) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 B.1.351 variant in a Biosafety Level 2 facility.
More Information
SKU 78142-2
Size 500 µl x 2
Application 1. Study the mechanism of viral transduction of SARS-CoV-2 B.1.351 variant.
2. Screening for neutralizing antibodies inhibiting the binding of SARS-CoV-2 Spike (B.1.351 variant) to ACE2.
Storage Lentiviruses are shipped with dry ice. For long term storage, it is recommended to store the virus at -80C. Avoid repeated freeze-thaw cycles. Titers can drop significantly with each freeze-thaw cycle.
Species SARS-CoV-2
Gene synonyms Sars-cov-2 B.1.351, 20H/501Y.V2, sars cov 2, sarscov2, South Africa variant, S. Africa lenti, South African mutation, B1351 lentivirus, pseudovirus, pseudovirion, 78142-1, 78142-2
Shipping Temp -80C
Supplier Name BPS